Inventurus Knowledge Solutions Limited (IKS Health), founded in 2006 and headquartered in Maharashtra, India, is a healthcare technology company that provides administrative and clinical support solutions to healthcare providers globally.
The company’s offerings include virtual medical scribing, clinical support, and medical documentation management. It supports both outpatient and inpatient care and serves over 800 healthcare organizations, including notable clients like Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management.
Inventurus Knowledge Solutions (IKS) Limited is a global healthcare solutions provider specializing in delivering innovative technology and process outsourcing services. The company primarily caters to the healthcare industry, offering solutions for revenue cycle management (RCM), data analytics, and patient engagement. Here are key details about the company:
Basic Information
- Full Name: Inventurus Knowledge Solutions Limited
- Industry: Healthcare and Business Process Outsourcing (BPO)
- Founded: 2007
- Headquarters: Mumbai, India
Inventurus Knowledge Solutions IPO Details
IPO Date | December 12, 2024 to December 16, 2024 |
Listing Date | December 19, 2024 |
Face Value | ₹1 per share |
Price Band | ₹1265 to ₹1329 per share |
Lot Size | 11 Shares |
Total Issue Size | 18,795,510 shares (aggregating up to ₹2,497.92 Cr) |
Offer for Sale | 18,795,510 shares of ₹1 (aggregating up to ₹2,497.92 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Share holding pre issue | 171,573,159 |
Share holding post issue | 171,573,159 |

Inventurus Knowledge Solutions IPO Promoter Holding
The promoters of Inventurus Knowledge Solutions Limited include Sachin Gupta, Rekha Jhunjhunwala, the Aryaman Jhunjhunwala Discretionary Trust, the Aryavir Jhunjhunwala Discretionary Trust, and the Nishtha Jhunjhunwala Discretionary Trust. These entities hold significant stakes and leadership roles in shaping the company’s direction
Share Holding Pre Issue | 69.73% |
Share Holding Post Issue | 60.61% |
Key highlights about the company:
- Employee Base: The company employs approximately 13,528 individuals, including 2,612 clinically trained professionals.
- Revenue Growth: It reported significant growth in revenues, with INR 1,858 crore in FY 2024, up from INR 1,060 crore in FY 2023
- Upcoming IPO: The company has an IPO scheduled from December 12 to December 16, 2024, with a price band of INR 1,265–1,329 per share. It plans to list on both BSE and NSE on December 19, 2024
Financial and Operational Strengths:
- Strong Market Position: Known for its comprehensive platform, innovative technology, and strategic partnerships with healthcare leaders.
- Financial Metrics: As of FY 2024, the company showed improvements in net worth and reserves, with a net profit of INR 370 crore
Challenges:
- Dependency on maintaining client relationships and the risks associated with integrating acquisitions such as Aquity Holdings
Also Need To Know -> Vishal Mega Mart Limited IPO: Everything You Need to Know
Also Need To Know -> Enviro Infra Engineers IPO Review: Everything You Need to Know
Disclaimer: The content on this website is intended for informational purposes only and should not be interpreted as financial or investment advice. Engaging in stock market activities involves inherent risks, and outcomes can be unpredictable. While we strive to provide accurate and up-to-date information, we do not make any guarantees regarding the completeness or reliability of the content. Any investment decisions you make should be based on your own research and consultation with a qualified financial professional. We are not responsible for any financial gains or losses resulting from actions taken based on the information provided here. Always invest wisely and at your own risk.